Ganciclovir Oral |
Cytoveve Capsules |
Pictures
cmv jpg
art ajt471920 fig1 jpg
art ajt471920 fig2 jpg
art ajt471920 fig3 jpg
virolo4 gif
hbvrep gif
slide14 gif
In that setting an oral agent would be more attractive and palatable to both clinicians and patients Certainly a great deal of effort needs to be made in the enhancement of immune responses Slide 14 Oral Ganciclovir A cautionary note about oral ganciclovir it is notable that its bioavailability is very poor only 6 to 9 of what is administered orally actually gets in the
slide16 gif
after administering valganciclovir is comparable to that which is achieved after intravenous ganciclovir 42 7 compared with 47 6 and is twice as good as that achieved after oral ganciclovir Slide 16 Conclusion In conclusion the challenge that we face today is that late CMV infection and disease rates are increasing Ganciclovir use before day 100 is a contributor to this
slide15 gif
this increased to 3 but after a course of oral ganciclovir it was much higher 6 5 Again the likelihood of the emergence of drug resistance is of great concern with this oral agent Slide 15 Valganciclovir Valganciclovir the prodrug actually has much greater bioavailability in the range of 60 so the area under the curve that is achieved after administering
valcyte image01 jpg
mL in water at 25°C at a pH of 7 0 and an n octanol water partition coefficient of 0 0095 at pH 7 0 The pKa for valganciclovir HCl is 7 6 The chemical structure of valganciclovir HCl is All doses in this insert are specified in terms of valganciclovir
acv gif
334 1491 1996 sugieren que la administración profiláctica de Ganciclovir oral puede reducir el riesgo de CMV en las personas con SIDA también es útil en los transplantados
valcyte image03 jpg
Distributed by 27899120 Copyright © 2001 2006 by Roche Laboratories Inc All rights reserved
CMVretinitis jpg
of CMV retinitis in patients with AIDS Roche presented data comparing treatment of CMV retinitis with oral valganciclovir to treatment with infusions of ganciclovir CMV retinitis SOURCE NATIONAL EYE INSTITUTE Over the past decade the treatment of people with HIV AIDS has changed dramatically which has made it more difficult to recruit
hs uknis marc jpg
Response from Marc E Uknis MD Associate Professor Department of Surgery Molecular Medicine and Microbiology University of Massachusetts Worcester
rnavirep gif
vidariba gif
DNA polimerasa es un análogo tipo pirofosfato NO ES un análogo de un nucleótido y NO requiere activación intracelular Es poco soluble y es potencialmente nefrotóxico
hivpr2 gif
solo una pequeña fracción ingerida pasa al torrente circulatorio y 2 cruzan muy mal la barrera hemato encefálica y por ende muy bajas concentraciones en el tejido cerebral
amarima2 gif
box5 8 gif
is the case with IV ganciclovir or foscarnet If IV foscarnet is used for maintenance the patient should have access to an infusion pump to avoid dangerous electrolyte disturbance Oral ganciclovir alone should not be used for induction treatment However it can be considered for maintenance therapy when other options are not feasible And it should be
box5 17 gif
Box 5 17 Ganciclovir is also effective but without added efficacy is too toxic for routine use Acyclovir is available in three formulations topical oral and intravenous Topical acyclovir 5 acyclovir ointment is available for topical application It achieves negligible systemic levels but does reduce slightly the duration of symptoms in primary

Not Signed In -

